Explore evidence

80 %Among 213 women aged 16 to 63 years recruited in Lagos, Nigeria, 150 out of 187 concordant results were HPV negative, representing 80% of concordant cases.

Nigeriainfection à HPVobserved 2020published 2022BMC public healthPubMeddocument of 5 observations

53.9 %The HPV vaccination rate among adolescent girls aged 9–17 was 53.9%.

Nigeriainfection à HPVpublished 2025PloS onePubMeddocument of 4 observations

71.1 %HPV prevalence in Ebonyi State, Nigeria, is 71.1%.

Nigeriainfection à HPVPubMeddocument of 7 observations

40.6 %40.6% of the participants with HPV data were negative for HPV.

Nigeriainfection à HPVobserved 2020–2022published 2023BMC cancerPubMeddocument of 14 observations

6.4 aORAnogenital warts increased the odds of awareness of HPV's carcinogenicity among sexual minority men living with HIV (adjusted odds ratio: 6.4, 95% confidence interval: 3.0–13.6).

Nigeriaanogenital warts · infection à HPV · VIH/sidapublished 2025Sexual healthPubMeddocument of 9 observations

4.8 aORAnogenital warts increased the odds of awareness of HPV's carcinogenicity among sexual minority men without HIV (adjusted odds ratio: 4.8, 95% confidence interval: 1.6–14.2).

Nigeriaanogenital warts · infection à HPVpublished 2025Sexual healthPubMeddocument of 9 observations

97 %Almost all participants (>97%) among 215 female secondary school students in Benin City, Nigeria had not heard of HPV, HPV vaccines, and cervical cancer.

Nigeriacancer du col de l'utérus · infection à HPVpublished 2020African health sciencesPubMeddocument of 3 observations

98.1 %98.1% of the 790 respondents reported a positive experience with HPV self-sampling.

Nigeriainfection à HPVpublished 2024African health sciencesPubMeddocument of 5 observations

84 %The prevalence of any HPV infection was 84% in the cervix among female sex workers in Ibadan, Nigeria.

Nigeriainfection à HPVpublished 2022PloS oneeurope_pmcdocument of 4 observations

48.1 %The northeast geopolitical zone of Nigeria had the highest pooled prevalence of HPV infection at 48.1%.

Nigeriainfection à HPVpublished 2021Annals of medicinePubMeddocument of 9 observations

32.1 %HPV-16 seroprevalence among women aged 35–39 years in Central Nigeria was 32.1%.

Nigeriainfection à HPVobserved August 2016 to January 2018published 2021The Pan African medical journalPubMeddocument of 17 observations

HPV vaccination uptake remains low in Nigeria.

Nigeriainfection à HPVpublished 2025Journal of health, population, and nutritionPubMeddocument of 5 observations

Abdominal vaginal discharge was significantly associated with HPV infection.

Nigeriainfection à HPVpublished 2021Annals of medicinePubMeddocument of 9 observations

99 %HPV infection has been detected in more than 99% of cervical cancers throughout the world.

Nigeriacancer du col de l'utérus · infection à HPVpublished 2024West African journal of medicinePubMeddocument of 4 observations

42.8 %Awareness of HPV among mothers of female secondary school students in Abakaliki was 42.8%.

Nigeriainfection à HPVpublished 2019Nigerian journal of clinical practicePubMeddocument of 7 observations

86.2 %Among HPV-positive individuals, 86.2% had high-risk HPV types.

Nigeriainfection à HPVpublished 2019PloS onePubMeddocument of 7 observations

10,764 participantsA total of 16 studies involving 10,764 participants met the eligibility criteria in the systematic review on HPV vaccination determinants in Nigeria.

Nigeriainfection à HPVpublished 2026BMC public healthPubMeddocument of 3 observations

45.2 %45.2% of the participants were positive for oral HPV only.

Nigeriainfection à HPVpublished 2025BMC oral healthPubMeddocument of 4 observations

28.6 %28.6% of patients with oropharyngeal carcinomas had more than one HPV genotype.

Nigeriainfection à HPV · oropharyngeal carcinomaspublished 2021The Pan African medical journalPubMeddocument of 4 observations

13.3 aORAmong HIV-positive participants in the TRUST/RV368 cohort, having 200 or less CD4 cells/mm³ was associated with highly similar anal HPV genotypes at 12 months (adjusted odds ratio 13.3, 95% CI 2.7–65.2).

Nigeriainfection à HPV · VIH/sidapublished 2022Sexually transmitted diseasesPubMeddocument of 13 observations

56.5 %In the study, 56.5% of the 801 students in four secondary schools in Benin City, Nigeria, had heard of the HPV vaccine.

Nigeriainfection à HPVpublished 2026International journal of gynaecology and obstetrics: the official organ of the InternationPubMeddocument of 10 observations

39 %The most significant barriers identified were lack of awareness (39%), vaccine availability (39%), and cost (13%).

Nigeriainfection à HPVpublished 2020Annals of global healthPubMeddocument of 10 observations

Persistent hrHPV infection was defined as detection of at least one carcinogenic HPV genotype in each of the samples provided at the baseline and follow-up visits.

NigeriahrHPV · infection à HPVpublished 2020BMC medical geneticsPubMeddocument of 6 observations

69.8 %Sixty-nine point eight percent of women had infections with one HPV strain.

Nigeriainfection à HPVpublished 2026Diagnostic microbiology and infectious diseasePubMeddocument of 21 observations

90 %Nigeria's HPV vaccination programme targets a coverage of 90%.

Nigeriainfection à HPVPubMeddocument of 4 observations